DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xkjzg9/breast_cancer) has announced the addition of the "Breast Cancer Drug Pipeline Update 2013" report to their offering.
Breast cancer is the leading cause of cancer-related mortality among women worldwide. Despite recent drug approvals in the adjuvant and metastatic setting, the overall survival remains below five years.
There are today 366 companies plus partners developing 508 drugs targeting breast cancer in development. In addition, there are 8 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 193 drugs. Breast Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 287 different targets. All included targets have been cross-referenced for the presence of mutations associated with human cancer. To date 279 out of the 282 studied drug targets so far have been recorded with somatic mutations. The software application lets you narrow in on these mutations and links out to the mutational analysis for each of the drug targets for detailed information. All drugs targets are further categorized on in the software application by 64 classifications of molecular function and with pathway referrals to BioCarta, KEGG, NCI-Nature and NetPath.
Drug Pipeline Update at a Glance
Includes more than 366 principal companies plus their collaborators. There is direct access from inside the application to web pages of all principal companies.
This Drug Pipeline Update contains 508 drugs in development for the treatment of breast cancer. In addition there are suspended and ceased drugs.
Included breast cancer drugs are also in development for 217 other indications, where of 111 are different cancer indications.
The identity of available biological structures on 198 drug targets was retrieved from the RCSB Protein Databank for you to easily review the 3450 structures available today among drug targets.
For more information visit http://www.researchandmarkets.com/research/xkjzg9/breast_cancer
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.